Last $2.81 USD
Change Today +0.125 / 4.66%
Volume 42.3K
VRML On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-François Formela M.D., MBA

AgeTotal Calculated CompensationThis person is connected to 149 board members in 21 different organizations across 26 different industries.

See Board Relationships
56--

Background*

Dr. Jean-François Formela, M.D., MBA is a Partner of Atlas Venture L.P., Atlas Venture Fund VII, L.P. and Atlas Venture Fund VI, L.P. Dr. Formela joined Atlas Venture in 1993 to build the U.S. life sciences franchise. He serves as an Executive at Vermillion, Inc. He is a Partner of the life sciences group and focuses on biopharmaceuticals sector and advances in biology and drug discovery technologies. He served as a Principal of Atlas Venture from 1993 to 1995. He spearheaded ...

Read Full Background

Corporate Headquarters*

Building III
Austin, Texas 78738

United States

Phone: 512-519-0400
Fax: 512-439-6980

Board Members Memberships*

Director
Director
Chairman
Director
Director
Former Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
1995-2005
Former Director
1996-2005
Former Director
1997-N/A
Former Director
1997-Present
Director
1999-N/A
Director, Member of Compensation Committee and Member of Corporate Governance & Nominating Committee
2000-2008
Former Director and Member of Compensation Committee
2003-2006
Former Director and Member of Nominating & Corporate Governance Committee
2003-2003
Former Director
2003-Present
Director
2006-2013
Former Director and Member of Compensation Committee
2010-Present
Director
2010-Present
Director and Member of Nominating & Corporate Governance Committee
2010-Present
Chairman
2014-Present
Director

Education*

MBA
Columbia University
MD
Medical University of Paris
MD
Ecole De Medecine De L'universite De Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $2.81 USD +0.125

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Russell Cummings Chief Executive Officer, Executive Director, and Member of Investment Committee
Imperial Innovations Group plc
210.0K GBP
Kevin Kowbel Chairman and Interim Chief Executive Officer
Health Discovery Corporation
--
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$219.6K
Rene A. Schena Chairman, Chief Executive Officer, Chief Financial Officer and Acting Principal Accounting Officer
Arrayit Corporation
--
Jan Groen Ph.D.Chief Executive Officer and Executive Director
MDxHealth SA
€462.0K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.